Adaptable modified virus vector to deliver ribosomal ribonucleic acid as a medical treatment device to manage diabetes mellitus and other protein deficient diseases

A medical treatment device consisting of a modified form of a virus carrying on its surface a quantity of probes that target cell-surface receptors on certain biologically active cells, said modified form of virus containing a quantity of ribosomal ribonucleic acid molecules for the purpose of inserting into said biologically active cell said quantity of ribosomal ribonucleic acid molecules that are capable of interacting with protein molecules that arrange to construct a ribosome, purpose of said ribosome to decode a messenger ribonucleic acid molecule, the result being to produce a specific protein inside said metabolically active cell for the purpose of carrying out a therapeutic medical treatment.

A medical treatment device consisting of a modified Hepatitis C virus, said Hepatitis C virus modified to have a quantity of surface probes to recognize, then engage one or more exterior cell-surface receptors on the surface of a Beta cell located in the Islets of Langerhans in the pancreas, said medical device expressing said quantity of surface probes intended to facilitate inserting said modified Hepatitis C virus's genome that it carries into said Beta cell, said modified Hepatitis C virus further modified to have its own innate positive sense ribonucleic acid genome replaced by a quantity of ribosomal ribonucleic acid molecules for the purpose of carrying out a medically therapeutic treatment,

• whereby once said modified Hepatitis C virus inserts said quantity of ribosomal ribonucleic acid molecules into said Beta cell, said quantity of ribosomal ribonucleic acid molecules are intended to engage ribosomal proteins to produce ribosomes, said ribosomes to decode messenger ribosomal acid molecules to produce proteins, the result of which is intended to produce a medically beneficial therapeutic effect.

A medical treatment device consisting of a virus-like transport vehicle comprised of an outer shell of bilayer lipid material, embedded in said bilayer lipid surface of said virus-like transport vehicle a quantity of probes intended to target cell-surface receptors on specific biologically active cells, said virus-like transport vehicle containing a quantity of nested protein shells, said virus-like transport vehicle carrying inside said bilayer lipid shell a quantity of ribosomal ribonucleic acid molecules for the purpose of inserting into said biologically active cell said quantity of said ribosomal ribonucleic acid molecules,

• whereby once said virus-like transport vehicle inserts said quantity of ribosomal ribonucleic acid molecules into said biologically active cell, said quantity of ribosomal ribonucleic acid molecules are intended to engage ribosomal proteins to produce ribosomes, said ribosomes to decode messenger ribosomal acid molecules to produce proteins, the result of which is intended to produce a medically beneficial therapeutic effect.